Arguably the most essential and indispensable aspect of life is achieving and maintaining good health. People suffering from health-related complications are often prevented from leading what many consider a normal lifestyle. Prostate cancer is one of many diseases that interfere with typical human functioning. The community of experts and professionals who have dedicated their lives to this field of study are, at present, engaged in a substantive, but controversial and highly controversial, debate regarding a test considered by some to aid in the detection of this cancer. This highly scrutinized test is known as the prostate-specific antigen test, more commonly known as the PSA test. In the United States and more widely around the world today, the prostate specific antigen test gives few or no positive results while being susceptible to damage and destruction and therefore should not be administered on a regular basis as means of detection. form of malignancy. Prostate cancer has retained its place as the leading source of cancer, after melanomas and skin carcinomas. Additionally, this disease is the second leading cause of death among men in the United States who die from cancer.1(p164) So what is the reason for such a polarized dialogue regarding a simple, relatively painless, diagnostic tool? non-invasive? The debate on this issue, although it had simmered within the scientific and medical fraternity for a long time, was actually brought to the forefront and to the forefront of the news in October 2011 when a group known as name of United States Preventative Services Task Force released its findings on the issue. The USPSTF report, considered mid-paper, reignites the debate over “over-selection.” PBS News Hour website. 2011. http://www.pbs.org/newshour/rundown/2011/10/psa-testing-controversy-reignites-over-screening-debate.html Accessed March 13, 2012.4. Parker-Pope T. Prostate cancer screening shows no benefit. New York Times Online. 2012. http://well.blogs.nytimes.com/2012/01/06/embargoed-no-benefit-from-prostate-cancer-screening/ Accessed March 13, 2012.5. Cauley, DH Chapter 150. Prostate cancer. In: Schwinghammer TL, Koehler JM, eds. Drug therapy casebook: a patient-centered approach. 8th ed. New York: McGraw-Hill; 2011. http://www.accesspharmacy.com/content.aspx?aID=55624057. Accessed March 13, 2012.6. Allan GM, Chetner M, Venner P et al. Advancing the debate on prostate cancer screening (prostate cancer-specific mortality and associated risks). Can Urol Assoc J. 2011; 5(6):416-421. DOI: 10.5489/piece.11063